SCHEMBL12606288

SCHEMBL12606288

Cc1noc(C)c1NC(=O)NCc1ccc2c(c1)c(-c1cc3cccnc3[nH]1)cn2C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.51
▸ IGF1R P08069 2/20 0.47
▸ KDR P35968 2/20 0.38
▸ JAK2 O60674 2/20 0.38
▸ GSK3B P49841 2/20 0.38
▸ CDK7 P50613 2/20 0.38
▸ LRRK2 Q5S007 2/20 0.38
▸ AURKB Q96GD4 2/20 0.38
▸ LCK P06239 1/20 0.38
▸ GSK3A P49840 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ NAMPT P43490 3/20 0.37
▸ ITK Q08881 1/20 0.36
▸ SCN9A Q15858 2/20 0.36
▸ RIPK1 Q13546 3/20 0.35
▸ SHMT2 P34897 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TRPV1 Q8NER1 2/20 0.34
▸ TAS2R8 Q9NYW2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12606282 0.83 SYK (0.58) SYKIGF1RKDRJAK2GSK3B
SCHEMBL12606292 0.82 SYK (0.61) SYKIGF1RKDRJAK2GSK3B
SCHEMBL12606271 0.79 SYK (0.66) SYKIGF1RKDRJAK2GSK3B
SCHEMBL12606314 0.78 SYK (0.53) SYKIGF1RJAK2GSK3BCDK7
SCHEMBL6421536 0.77 SYK (0.49) SYKIGF1RKDRJAK2GSK3B
SCHEMBL12606259 0.76 IGF1R (0.58) SYKIGF1RKDRJAK2GSK3B
SCHEMBL12606280 0.76 SYK (0.51) SYKIGF1RKDRJAK2GSK3B
SCHEMBL12606327 0.76 SYK (0.53) SYKIGF1RKDRJAK2GSK3B
SCHEMBL1778605 0.75 SYK (0.61) SYKIGF1RJAK2GSK3BCDK7
SCHEMBL12606307 0.75 SYK (0.53) SYKIGF1RKDRJAK2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943616-B2 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders AVENTIS PHARMACEUTICALS INC. (US) 2011-05-17 — — US disclosed
US-7943616-B2 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders AVENTIS PHARMACEUTICALS INC. (US) 2011-05-17 — — US disclosed
EP-2233486-A1 Azaindoles Aventis Pharma Limited (GB) 2010-09-29 — — EP disclosed
Send feedback